Published in Proc Natl Acad Sci U S A on January 01, 1971
Detection of specific hybridoma clones by replica immunoadsorption of their secreted antibodies. Proc Natl Acad Sci U S A (1979) 13.60
A monoclonal antibody against a 135-K Golgi membrane protein. EMBO J (1982) 4.89
Consequences of frameshift mutations at the immunoglobulin heavy chain locus of the mouse. EMBO J (1985) 3.25
Interactions and three-dimensional localization of a group of nuclear pore complex proteins. J Cell Biol (1994) 2.63
Expression of immunoglobulin heavy chain at a high level in the absence of a proposed immunoglobulin enhancer element in cis. Proc Natl Acad Sci U S A (1984) 2.55
Repertoire of antiviral antibodies expressed by somatic cell hybrids. Proc Natl Acad Sci U S A (1978) 2.38
Cell-free translation of immunoglobulin messenger RNA from MOPC-315 plasmacytoma and MOPC-315 NR, a variant synthesizing only light chain. Proc Natl Acad Sci U S A (1975) 2.37
On immunoglobulin heavy chain gene switching: two gamma 2b genes are rearranged via switch sequences in MPC-11 cells but only one is expressed. Nucleic Acids Res (1982) 2.29
Myeloma proteins as tumor-specific transplantation antigens. Proc Natl Acad Sci U S A (1972) 2.09
A monoclonal antibody to the heavy chain of clathrin. EMBO J (1983) 1.94
How antibodies fold. Trends Biochem Sci (2009) 1.88
Variants of a mouse myeloma cell line that synthesize immunoglobulin heavy chains having an altered serotype. Proc Natl Acad Sci U S A (1975) 1.87
Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. J Exp Med (1989) 1.76
Variants of mouse myeloma cells that produce short immunoglobulin heavy chains. Proc Natl Acad Sci U S A (1974) 1.66
Mutations affecting the structure and function of immunoglobulin M. Mol Cell Biol (1982) 1.58
Isolation of myeloma variants with predefined variant surface immunoglobulin by cell sorting. Proc Natl Acad Sci U S A (1978) 1.46
Immunoglobulin synthesis and secretion. VI. Synthesis and intracellular transport of immunoglobulin in nonsecretory lymphoma cells. J Exp Med (1971) 1.45
Immunoglobulin chain loss in hybridoma lines. Proc Natl Acad Sci U S A (1980) 1.44
Transcription in vitro of immunoglobulin kappa light chain genes in isolated mouse myeloma nuclei and chromatin. Proc Natl Acad Sci U S A (1976) 1.38
Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy. Proc Natl Acad Sci U S A (2000) 1.36
IgG2a-producing variants of an IgG2b-producing mouse myeloma cell line. J Exp Med (1978) 1.34
Fine specificity of antibodies to poly(Glu60Ala30Tyr10) produced by hybrid cell lines. Proc Natl Acad Sci U S A (1979) 1.32
A theory of allelic and isotypic exclusion for immunoglobulin genes. Proc Natl Acad Sci U S A (1982) 1.31
Cloning and sequence of the cDNA corresponding to the variable region of immunoglobulin heavy chain MPC11. Nucleic Acids Res (1980) 1.29
An immunoglobulin mutator that targets G.C base pairs. Proc Natl Acad Sci U S A (1996) 1.26
DNA rearrangements in MPC-11 immunoglobulin heavy chain class-switch variants. Proc Natl Acad Sci U S A (1982) 1.21
Immunoglobulin gene transcription ceases upon deletion of a distant enhancer. EMBO J (1995) 1.20
Cell-bound myeloma proteins on the surface of myeloma cells: potential targets for the immune system. Proc Natl Acad Sci U S A (1972) 1.20
Estimation of light-chain gene reiteration of mouse immunoglobulin by DNA-RNA hybridization. Proc Natl Acad Sci U S A (1973) 1.16
cDNA cloning of the immunoglobulin heavy chain binding protein. Proc Natl Acad Sci U S A (1988) 1.16
Isolation of a heterogeneous population of temperature-sensitive mutants of measles virus from persistently infected human lymphoblastoid cell lines. J Exp Med (1978) 1.10
Loss of a consensus splice signal in a mutant immunoglobulin gene eliminates the CH1 domain exon from the mRNA. Mol Cell Biol (1984) 1.09
Immunoglobulin heavy chain toxicity in plasma cells is neutralized by fusion to pre-B cells. Proc Natl Acad Sci U S A (1984) 1.08
Structural correlates of high antibody affinity: three engineered amino acid substitutions can increase the affinity of an anti-p-azophenylarsonate antibody 200-fold. Proc Natl Acad Sci U S A (1990) 1.06
Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma. Clin Exp Immunol (1976) 1.05
Derivation and diversification of monoclonal antibodies. EMBO J (1985) 0.99
Induction of anti-tobacco mosaic virus antibodies in mice by rabbit antiidiotypic antibodies. J Exp Med (1984) 0.98
High rates of deletions in the constant region segment of the immunoglobulin mu gene. Proc Natl Acad Sci U S A (1987) 0.95
Alteration of immunoglobulin phenotype in cell culture-adapted lines of two mouse plasmacytomas. J Exp Med (1975) 0.95
Mutations that influence the secretory path in animal cells. Biochem J (1983) 0.92
Discontinuous variability, in the form of a geometric progression, of albumin production in hepatoma and hybrid cells. Proc Natl Acad Sci U S A (1974) 0.92
Independent expression of the gene coding for the constant domain of immunoglobulin light chain: evidence from sequence analyses of the precursor of the constant region polypeptide. Proc Natl Acad Sci U S A (1977) 0.90
Identification and characterization of rabbit-mouse hybridomas secreting rabbit immunoglobulin chains. Proc Natl Acad Sci U S A (1980) 0.90
Spontaneous loss and alteration of antigen receptor expression in mature CD4+ T cells. J Exp Med (1990) 0.87
Tumorigenesis mediated by an antigen receptor. Proc Natl Acad Sci U S A (1992) 0.85
Morphologic and functional characteristics of long-term cultures of murine myeloma cells. Am J Pathol (1972) 0.84
Surface immunoglobulin of a mouse T-cell lymphoma. Immunology (1974) 0.84
Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains. J Virol (1999) 0.83
DNA rearrangement causes a high rate of spontaneous mutation at the immunoglobulin heavy-chain locus of a mouse myeloma cell line. Mol Cell Biol (1986) 0.83
Clonal variation in albumin messenger RNA activity in hepatoma cells. Proc Natl Acad Sci U S A (1976) 0.81
Genetic control of melanization: isolation and analysis of amelanotic variants from cultured melanotic melanoma cells. Proc Natl Acad Sci U S A (1974) 0.81
Fluorescent labeling in semi-solid medium for selection of mammalian cells secreting high-levels of recombinant proteins. BMC Biotechnol (2009) 0.81
Independent synthesis of light and heavy chains: quantitation of light-chain production by mouse myeloma variants. J Exp Med (1974) 0.80
Characterization of monoclonal antibodies to the sperm-specific lactate dehydrogenase isozyme. Proc Natl Acad Sci U S A (1983) 0.78
A comparison of nucleoside (beta-S)triphosphates and nucleoside (gamma-S)triphosphates as suitable substrates for measuring transcription initiation in preparations of cell nuclei. Nucleic Acids Res (1982) 0.78
Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. Nucleic Acids Res (1991) 0.75
Mutations of Bacteria from Virus Sensitivity to Virus Resistance. Genetics (1943) 165.64
The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci (1966) 9.68
Acrylamide-gel electrophorograms by mechanical fractionation: radioactive adenovirus proteins. Science (1966) 9.59
Cellular localization of immunoglobulins with different allotypic specificities in rabbit lymphoid tissues. J Exp Med (1965) 6.93
The cloning of normal "mast" cells in tissue culture. J Cell Physiol (1965) 5.47
Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits. J Exp Med (1970) 4.26
Mechanism of antibody diversity: germ line basis for variability. Science (1970) 3.05
Genetics of somatic mammalian cells. IX. Quantitation of mutagenesis by physical and chemical agents. J Cell Physiol (1969) 2.82
HEAVY CHAIN DISEASE- A NEW DISORDER OF SERUM GAMMA-GLOBULINS : REPORT OF THE FIRST CASE. Am J Med (1964) 2.59
Isolation and characterization of thymidine transport mutants of Chinese hamster cells. Exp Cell Res (1969) 2.27
DISORDERS IN THE DIFFERENTIATON OF PROTEIN SECRETION IN NEOPLASTIC PLASMA CELLS. J Mol Biol (1964) 2.09
ISOLATION AND STUDY OF MUTANTS FROM MAMMALIAN CELLS IN CULTURE. Proc Natl Acad Sci U S A (1959) 1.87
Immunoglobulin production: method for quantitatively detecting variant myeloma cells. Science (1970) 1.81
CHROMOSOME PREPARATIONS FROM SOLID TUMORS OF THE MOUSE: A DIRECT METHOD. Can J Genet Cytol (1965) 1.74
Genes and immunoglobulins. Vox Sang (1967) 1.47
Immunoglobulins and immunocytes. Bacteriol Rev (1969) 1.45
Mammalian cell genetics. I. Selection and characterization of mutations auxotrophic for L-glutamine or resistant to 8-azaguanine in Chinese hamster cells in vitro. Genetics (1969) 1.42
Studies on cell-free synthesis of rat immunoglobulins, II. Synthesis of immunoglobulin and of antibody to the dinitrophenyl hapten. Proc Natl Acad Sci U S A (1967) 1.32
Immunoglobulin biosynthesis. II. Four independently isolated myeloma variants. J Mol Biol (1968) 1.21
M-components in immunoproliferative disorders. Electrophoretic and immunologic analysis of 200 cases. Am J Clin Pathol (1967) 1.08
2-chain immunoglobulin A molecules: abnormal or normal intermediates in synthesis. Science (1968) 1.06
Macromolecular action of nitrosoguanidine in Escherichia coli. Biochim Biophys Acta (1967) 1.00
Genetics of human cell lines. II. Method for determination of mutation rates to drug resistance. Exp Cell Res (1959) 0.96
The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology (1968) 7.42
A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet (1977) 5.65
Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits. J Exp Med (1970) 4.26
The polypeptides of adenovirus. II. Soluble proteins, cores, top components and the structure of the virion. Virology (1968) 4.19
Rapidly labeled, polyribosome-associated RNA having the properties of histone messenger. Proc Natl Acad Sci U S A (1967) 4.12
Preparation of mammalian polyribosomes with the detergent Nonidet P-40. Biochim Biophys Acta (1967) 3.81
Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies. Hybridoma (1981) 3.58
Polyribosomal synthesis and assembly of the H and L chains of gamma globulin. Proc Natl Acad Sci U S A (1966) 3.53
Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci U S A (1984) 3.35
Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun (1992) 3.21
Somatic cell hybridization of mouse myeloma cells. Cell (1976) 3.17
Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis (1992) 2.98
Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J Immunol Methods (1992) 2.97
Molecular cloning and expression of the mouse ornithine decarboxylase gene. Proc Natl Acad Sci U S A (1984) 2.83
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother (1998) 2.74
Cloning of mouse myeloma cells and detection of rare variants. J Cell Physiol (1972) 2.63
The role of somatic hypermutation in the generation of antibody diversity. Science (1989) 2.55
The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. J Immunol (1978) 2.38
Synthesis and assembly of adenovirus 2. I. Polypeptide synthesis, assembly of capsomeres, and morphogenesis of the virion. Virology (1969) 2.27
Mutations causing charge alterations in regulatory subunits of the cAMP-dependent protein kinase of cultured S49 lymphoma cells. Cell (1977) 2.20
Cell cycle analysis by flow cytometry. Methods Enzymol (1979) 2.18
Inhibition of protein synthesis stabilizes histone mRNA. Mol Cell Biol (1984) 2.14
The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. J Exp Med (1991) 2.11
Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J Exp Med (1995) 2.11
Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med (1993) 2.09
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect Immun (1994) 2.07
Prevention of rapid intracellular degradation of ODC by a carboxyl-terminal truncation. Science (1989) 2.07
Extensive allelic variation in Cryptococcus neoformans. J Clin Microbiol (1992) 2.06
Antigen-binding mutants of mouse myeloma cells. Proc Natl Acad Sci U S A (1977) 2.04
The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol (1992) 2.02
Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob Agents Chemother (1994) 2.00
Sequestered end products and enzyme regulation: the case of ornithine decarboxylase. Microbiol Rev (1992) 1.98
Mutations in immunoglobulin-producing mouse myeloma cells. Science (1973) 1.94
Variants of a mouse myeloma cell line that synthesize immunoglobulin heavy chains having an altered serotype. Proc Natl Acad Sci U S A (1975) 1.87
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc Natl Acad Sci U S A (1993) 1.86
Return to the past: the case for antibody-based therapies in infectious diseases. Clin Infect Dis (1995) 1.86
Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J Exp Med (2000) 1.82
Immunoglobulin production: method for quantitatively detecting variant myeloma cells. Science (1970) 1.81
Lymphoblastoid cell lines from patients with chronic lymphocytic leukemia: identification of tumor origin by idiotypic analysis. Proc Natl Acad Sci U S A (1978) 1.78
The polypeptides of adenovirus. 3. Synthesis in infected cells. Virology (1969) 1.77
Selection of a variant lymphoma cell deficient in adenylate cyclase. Science (1975) 1.76
Degradation of ornithine decarboxylase: exposure of the C-terminal target by a polyamine-inducible inhibitory protein. Mol Cell Biol (1993) 1.75
G1 and S phase mammalian cells synthesize histones at equivalent rates. Cell (1980) 1.75
Heavy chain-producing variants of a mouse myeloma cell line. J Immunol (1975) 1.73
T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc Natl Acad Sci U S A (1997) 1.72
Synthesis of ribosomal RNA in synchronized HeLa cells. Nature (1965) 1.69
Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J Immunol (1995) 1.67
Synthesis of excess light chains of gamma globulin by rabbit lymph node cells. Nature (1966) 1.66
Variants of mouse myeloma cells that produce short immunoglobulin heavy chains. Proc Natl Acad Sci U S A (1974) 1.66
Polyribosome disaggregation during metaphase. Science (1966) 1.61
Cloning and sequencing of the ornithine decarboxylase gene from Trypanosoma brucei. Implications for enzyme turnover and selective difluoromethylornithine inhibition. J Biol Chem (1987) 1.61
Nucleic acid and protein sequences of phosphocholine-binding light chains. J Exp Med (1981) 1.61
Effect of adenovirus on host cell DNA synthesis in synchronized cells. Virology (1969) 1.61
Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A (1997) 1.61
Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J Exp Med (1997) 1.60
Two kappa immunoglobulin genes are expressed in the myeloma S107. Cell (1981) 1.60
Regulated degradation of ornithine decarboxylase requires interaction with the polyamine-inducible protein antizyme. Mol Cell Biol (1992) 1.57
Synthesis of a carboxyl-terminal (constant region) fragment of the immunoglobulin light chain by a mouse myeloma cell line. J Mol Biol (1974) 1.54
Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth. Science (1975) 1.51
Suppression of immunoglobulin synthesis by cellular hybridization. Nat New Biol (1971) 1.50
Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob Agents Chemother (1994) 1.48
Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A (1982) 1.46
Mouse ornithine decarboxylase gene: cloning, structure, and expression. Proc Natl Acad Sci U S A (1988) 1.46
Ubiquitin-free routes into the proteasome. Cell Mol Life Sci (2004) 1.45
Somatic genetic analysis of cyclic AMP action: selection of unresponsive mutants. J Cell Physiol (1975) 1.44
Two-dimensional gel analysis of cyclic AMP effects in cultured S49 mouse lymphoma cells: protein modifications, inductions and repressions. Cell (1979) 1.44
Trypanosome ornithine decarboxylase is stable because it lacks sequences found in the carboxyl terminus of the mouse enzyme which target the latter for intracellular degradation. J Biol Chem (1990) 1.43
Mouse ornithine decarboxylase. Complete amino acid sequence deduced from cDNA. J Biol Chem (1985) 1.42
High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J Virol (1996) 1.42
Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J Mol Biol (1996) 1.41
Serum therapy revisited: animal models of infection and development of passive antibody therapy. Antimicrob Agents Chemother (1994) 1.41
Agonist-specific refractoriness induced by isoproterenol. Studies with mutant cells. J Biol Chem (1976) 1.39
Somatic mutation in a cultured mouse myeloma cell affects antigen binding. Proc Natl Acad Sci U S A (1982) 1.39
Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line. Int Immunol (2001) 1.36
A structural gene mutation affecting the regulatory subunit of cyclic AMP-dependent protein kinase in mouse lymphoma cells. Proc Natl Acad Sci U S A (1975) 1.36
IgG2a-producing variants of an IgG2b-producing mouse myeloma cell line. J Exp Med (1978) 1.34
Multiple mechanisms are responsible for altered expression of ornithine decarboxylase in overproducing variant cells. Mol Cell Biol (1986) 1.34
A mouse lymphoma cell mutant whose major protein product is ornithine decarboxylase. J Biol Chem (1983) 1.33
Rat anti-T15 monoclonal antibodies with specificity for VH- and VH-VL epitopes. Mol Immunol (1984) 1.33
Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect Immun (2001) 1.32
IgG1 and IgG2b share the Fc receptor on mouse macrophages. J Immunol (1980) 1.31
Structure of mammalian ornithine decarboxylase at 1.6 A resolution: stereochemical implications of PLP-dependent amino acid decarboxylases. Structure (1999) 1.31
Polyamine-mediated regulation of mouse ornithine decarboxylase is posttranslational. Mol Cell Biol (1989) 1.30
Fusion of mouse myeloma and spleen cells. Curr Top Microbiol Immunol (1978) 1.30
Structural elements of ornithine decarboxylase required for intracellular degradation and polyamine-dependent regulation. Mol Cell Biol (1992) 1.30
Regulation of immunoglobulin expression in mouse myeloma cells. Cold Spring Harb Symp Quant Biol (1977) 1.28
Identification of rare immunoglobulin switch variants using the ELISA spot assay. J Immunol Methods (1992) 1.28
Ornithine decarboxylase in difluoromethylornithine-resistant mouse lymphoma cells. Two-dimensional gel analysis of synthesis and turnover. J Biol Chem (1983) 1.28
Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. 3. Assembly of the three subclasses of IgG. J Exp Med (1971) 1.27
Kinase-negative mutants of S49 mouse lymphoma cells carry a trans-dominant mutation affecting expression of cAMP-dependent protein kinase. Cell (1978) 1.27
Error-prone candidates vie for somatic mutation. J Exp Med (2000) 1.27
Mutagenesis of mouse myeloma cells with 'Melphalan'. Nature (1973) 1.27
Synthesis, assembly and secretion of gamma-globulin by mouse myeloma cells. V. Balanced and unbalanced synthesis of heavy and light chains by IgG-producing tumors and cell lines. J Immunol (1973) 1.26
Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J Exp Med (1998) 1.24
Synthesis and assembly of immunoglobulins by malignant human plasmacytes. I. Myelomas producing gamma-chains and light chains. J Exp Med (1970) 1.23
Point mutations cause the somatic diversification of IgM and IgG2a antiphosphorylcholine antibodies. J Exp Med (1988) 1.23